CollPlant Biotechnologies Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. CollPlant Biotechnologies Ltd.'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 3565% to $10,959,000. The net income raised on -$7,019,000 and profit margin reached -64%. Total operating expenses were $16,480,000.

Profit Margin

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN): Profit margin
2014 0 -3.34M
2015 0 -4.78M
2016 75.91K -7.23M -9537.05%
2017 479.91K -6.05M -1260.84%
2018 4.78M -6.24M -130.5%
2019 2.31M -14.69M -634.04%
2020 6.13M -5.80M -94.64%
2021 15.64M 409K 2.61%
2022 299K -16.75M -5603.01%
2023 10.95M -7.01M -64.05%

CLGN Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
10.95M299K15.64M6.13M2.31M4.78M479.91K75.91K00
Cost of revenue
1.99M400K2.00M3.00M1.87M378.63K14.96K0202.81K0
Gross profit
8.96M-101K13.63M3.13M439K4.40M464.95K75.91K-202.81K0
Operating exp.
Research and development
10.48M10.25M7.63M4.06M4.41M5.16M4.04M4.36M3.03M2.49M
Selling and marketing
00048K0000042.37K
Total operating expenses
16.48M16.99M13.57M8.73M8.07M8.47M6.43M7.23M4.81M3.50M
Operating income
-7.51M-17.09M65K-5.59M-7.63M-4.06M-5.97M-7.16M-4.81M-3.50M
Other income (expenses), net
493K172K172K-175K-3.53M378.36K-94K-90.46K50.86K156.32K
Income before tax
-7.01M-16.92M237K-5.77M-11.16M-3.68M-6.00M-7.25M-4.77M-3.34M
Income tax expense
0-172K-172K34K3.53M2.95M28.44K-86.28K63.85K162.83K
Net income
-7.01M-16.75M409K-5.80M-14.69M-6.24M-6.05M-7.23M-4.78M-3.34M
Earnings per share
Basic EPS
-0.62-1.520.04-0.84-2.95-1.43-2.27-3.6-2.83-2.08
Diluted EPS
-0.62-1.520.03-0.84-2.95-1.43-2.27-3.6-2.83-2.08
Data sourceData sourceData sourceData sourceData sourceData sourceData source